Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Hibercell Inc.
Headquarters: New York, NY, United States of America
Website: https://www.hibercell.com
Year Founded: 2019
Status: Private
BioCentury | Jul 25, 2024
Management Tracks
Mirati vet Charles Baum named CEO at Terremoto
Plus: Dave Daly at the helm at Exai Bio, and updates from Epitopea and FDA
BioCentury | Dec 13, 2023
Management Tracks
Magargee named CEO of Genentech
Plus: Garay steps down Moderna’s head of commercial and updates from MaxCyte, Aiolos, Corsair, BioXcel and more
BioCentury | Oct 29, 2021
Discovery & Translation
Omics-based target identification in UK Biobank and COVID-19 cohorts
Plus: technologies from Harvard, Texas A&M, Disney lab and more
BioCentury | Oct 1, 2021
Management Tracks
Marro becomes CFO at ObsEva
Plus: HiberCell, Isarna, Genenta and ImmunOs
BioCentury | Jul 1, 2021
Management Tracks
Greune joins CureVac as COO; plus Azafaros names Ultragenyx vet Portolano as CEO and updates from Tenaya, Ambrx, BioSkryb, HiberCell and more
mRNA company CureVac N.V. (NASDAQ:CVAC) hired Malte Greune as COO. He joins from Sanofi-Aventis Deutschland GmbH, where he served for nine years, most recently as general manager and VP of the
BioCentury | Jun 9, 2021
Management Tracks
More C-suite changes for Karyopharm; plus moves at Intercept, Chinook, Palleon, Napo, IMV and more
In another change in the C-suite of Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Chief Commercial Officer John Demaree and SVP of Sales Perry Monaco are leaving to pursue other opportunities. The
BioCentury | May 19, 2021
Deals
May 19 Quick Takes: AI play Exscientia expands BMS collaboration; plus HiberCell, eureKARE and RWE Alliance
Less than a month after raising a $525 million series D round led by Softbank, Oxford, U.K.-based AI play Exscientia Ltd. has expanded its collaboration with Bristol Myers Squibb Co. (NYSE:BMY) to
BioCentury | Jul 7, 2020
Deals
July 7 Quick Takes: Luminary-Case Western partner on BLyS-targeting CAR T; plus Dragonfly-BMS, HiberCell-Biothera and Biogen-Mass Eye and Ear
BioCentury | Aug 7, 2019
Company News
Management tracks: Gilead's McHutchison joins Assembly as CEO; plus Lilly, Vor, HiberCell, insitro and more
BioCentury | Feb 13, 2019
Financial News
Arch-backed HiberCell launches with over $60M to target dormant cancer cells
Items per page:
1 - 10 of 12